ROCK inhibition extends passage of pluripotent stem cell-derived retinal pigmented epithelium

Stem Cells Translational Medicine

Volumn 3, Issue 9, 2014, Pages 1066-1078

  Croze, Roxanne H ^a   Buchholz, David E ^a   Radeke, Monte J ^a   Thi, William J ^a   Hu, Qirui ^a   Coffey, Peter J ^a   Clegg, Dennis O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell culture; Cell proliferation; Cellular therapy; Embryonic stem cells; Retinal pigmented epithelium

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL) CYCLOHEXANECARBOXAMIDE; ALPHA2 INTEGRIN; CD31 ANTIGEN; EUKARYOTIC TRANSLATION INITIATION FACTOR 2B; GROWTH DIFFERENTIATION FACTOR 6; KI 67 ANTIGEN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICROTUBULE ASSOCIATED PROTEIN 2; NUCLEIC ACID BINDING PROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; PREMELANOSOME PROTEIN; PROTEIN ZO1; RHO ASSOCIATED COILED COIL PROTEIN KINASE; RHO ASSOCIATED COILED COIL PROTEIN KINASE 1; RHO ASSOCIATED COILED COIL PROTEIN KINASE 2; RHO KINASE; RHO KINASE INHIBITOR; TRANSCRIPTION FACTOR OTX2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR ANTIGEN; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 42; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMIDE; ENZYME INHIBITOR; PYRIDINE DERIVATIVE;

ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL PHAGOCYTOSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION ASSAY; GENOME; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MICROARRAY ANALYSIS; MTT ASSAY; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD OUTER SEGMENT; RNA ISOLATION; WNT SIGNALING PATHWAY; ANTAGONISTS AND INHIBITORS; CELL CULTURE TECHNIQUE; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; EMBRYONIC STEM CELL; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; PHYSIOLOGY; PROCEDURES; RETINAL PIGMENT EPITHELIUM;

AMIDES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLURIPOTENT STEM CELLS; PYRIDINES; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL PIGMENT EPITHELIUM; RHO-ASSOCIATED KINASES;

EID: 84906862141     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0079     Document Type: Article

References (75)

1. Croze RH, Clegg DO. Differentiation of pluripotent stem cells into retinal pigmented epithelium. In: Casaroli-Marano RP, Zarbin MA, eds. Developments in Opthalmology. Vol. 53. Cell-Based Therapy for Retinal Degenerative Disease. Basel, Germany: Karger, 2014:81-96.
2. Schwartz SD, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012;379:713-720.
3. Klein R, Chou CF, Klein BE et al. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011;129:75-80.
4. Friedman DS, O'Colmain BJ, Muñoz B et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-572.
5. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996; 37:1236-1249.
6. Young RW. Pathophysiology of agerelated macular degeneration. Surv Ophthalmol 1987;31:291-306.
7. Gehrs KM, Anderson DH, Johnson LV et al. Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 2006;38:450-471.
8. Bird AC. Therapeutic targets in age-related maculardisease. J ClinInvest2010;120:3033-3041.
9. Ferris FL III., Wilkinson CP, Bird A et al. Clinical classification of age-related macular degeneration. Ophthalmology 2013;120:844-851.
10. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436.
11. Bowes Rickman C, Farsiu S, Toth CA et al. Dry age-related macular degeneration: Mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci 2013;54:ORSF68-80.
12. Buchholz DE, Hikita ST, Rowland TJ et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. STEM CELLS 2009;27:2427-2434.
13. Bharti K, Rao M, Hull SC et al. Developing cellular therapies for retinaldegenerativediseases. Invest Ophthalmol Vis Sci 2014;55:1191-1202.
14. Rowland TJ, Buchholz DE, Clegg DO. Pluripotent human stem cells for the treatment of retinal disease. J Cell Physiol 2012;227: 457-466.
15. Burke JM. Epithelial phenotype and the RPE: Is the answer blowing in the Wnt? Prog Retin Eye Res 2008;27:579-595.
16. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 1995;36:391-405.
17. Lee SC, Kwon OW, Seong GJ et al. Epitheliomesenchymal transdifferentiation of cultured RPE cells. Ophthalmic Res 2001;33:80-86.
18. Singh R, Phillips MJ, Kuai D et al. Functional analysis of serially expanded human iPS cell-derived RPE cultures. Invest Ophthalmol Vis Sci 2013;54:6767-6778.
19. Feng Q, Lu SJ, Klimanskaya I et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. STEM CELLS 2010;28: 704-712.
20. Shay JW, Wright WE. Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 2000;1:72-76.
21. Riento K, Ridley AJ. Rocks: Multifunctional kinases in cell behaviour. Nat Rev MolCell Biol 2003;4:446-456.
22. Amano M, Fukata Y, Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp Cell Res 2000;261:44-51.
23. Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 2007; 50:17-24.
24. Leung T, Chen XQ, Manser E et al. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 1996;16:5313-5327.
25. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and nonmuscle myosin II. J Physiol 2000;522:177-185.
26. Street CA, Bryan BA. Rho kinase proteins-pleiotropic modulators of cell survival and apoptosis. Anticancer Res 2011;31:3645-3657.
27. Doggrell SA. Rho-kinase inhibitors show promise in pulmonary hypertension. Expert Opin Investig Drugs 2005;14:1157-1159.
28. Pankey EA, Byun RJ, Smith WB II et al. The Rho kinase inhibitor azaindole-1 has long-acting vasodilator activity in the pulmonary vascular bed of the intact chest rat. Can J Physiol Pharmacol 2012;90:825-835.
29. Zhou Q, Gensch C, Liao JK. Rhoassociated coiled-coil-forming kinases (ROCKs): Potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci 2011;32:167-173.
30. Okumura N, Ueno M, Koizumi N et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci 2009;50:3680-3687.
31. Koizumi N, Okumura N, Kinoshita S. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Exp Eye Res 2012;95: 60-67.
32. Liu X, Ory V, Chapman S et al. ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. Am J Pathol 2012;180:599-607.
33. Horani A, Nath A, Wasserman MG et al. Rho-associated protein kinase inhibition enhances airway epithelial basal-cell proliferation and lentivirus transduction. AmJ Respir CellMolBiol 2013;49:341-347.
34. Miyashita H, Yokoo S, Yoshida S et al. Long-term maintenance of limbal epithelial progenitor cells using rho kinase inhibitor and keratinocyte growth factor. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:758-765.
35. van den Bogaard EH, Rodijk-Olthuis D, Jansen PA et al. Rho kinase inhibitor Y-27632 prolongs the life span of adult human keratinocytes, enhances skin equivalent development, and facilitates lentiviral transduction. Tissue Eng Part A 2012;18:1827-1836.
36. Chapman S, Liu X, Meyers C et al. Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 2010;120: 2619-2626.
37. Ohgushi M, Matsumura M, Eiraku M et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 2010;7:225-239.
38. Ohgushi M, Sasai Y. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states. Trends Cell Biol 2011;21:274-282.
39. Buchholz DE, Pennington BO, Croze RH et al. Rapid and efficient directed differentiation of humanpluripotent stem cells into retinal pigmented epithelium. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:384-393.
40. Diniz B, Thomas P, Thomas B et al. Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: Improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci 2013;54: 5087-5096.
41. Maminishkis A, Chen S, Jalickee S et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci 2006;47:3612-3624.
42. Molday RS, Hicks D, Molday L. Peripherin. A rim-specific membrane protein of rod outer segment discs. Invest Ophthalmol Vis Sci 1987; 28:50-61.
43. RowlandTJ, BlaschkeAJ, BuchholzDEet al. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J Tissue Eng Regen Med 2013;7: 642-653.
44. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005;85: 845-881.
45. Lin H, Clegg DO. Integrin alphavbeta5 participates in the binding of photoreceptor rod outer segments during phagocytosis by cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1998;39:1703-1712.
46. Duong-Quy S, Bei Y, Liu Z et al. Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacol Ther 2013;137:352-364.
47. AmanoM, Nakayama M, Kaibuchi K. Rhokinase/ ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 2010;67:545-554.
48. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
49. Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009;37:1-13.
50. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. STEM CELLS 2001;19: 193-204.
51. Klimanskaya I, Hipp J, Rezai KA et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004;6:217-245.
52. Idelson M, Alper R, Obolensky A et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009;5:396-408.
53. Zahabi A, Shahbazi E, Ahmadieh H et al. A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev 2012;21:2262-2272.
54. Zhu Y, Carido M, Meinhardt A et al. Three-dimensional neuroepithelial culture from human embryonic stem cells and its use for quantitative conversion to retinal pigment epithelium. PLoS One 2013;8:e54552.
55. Lee SC, Kim SH, Koh HJ et al. TGF-betas synthesized by RPE cells have autocrine activity on mesenchymal transformation and cell proliferation. Yonsei Med J 2001;42:271-277.
56. Son H, Moon A. Epithelial-mesenchymal transition and cell invasion. Toxicol Rev 2010; 26:245-252.
57. Xiao L, Wang M, Yang S et al. A glimpse of the pathogenetic mechanisms of Wnt/b-catenin signaling in diabetic nephropathy. Biomed Res Int 2013;2013:987064.
58. Billings PC, Whitbeck JC, Adams CS et al. The transforming growth factor-b-inducible matrix protein big-h3 interacts with fibronectin. J Biol Chem 2002;277:28003-28009.
59. Kim JE, Park RW, Choi JY et al. Molecular properties of wild-type and mutant betaIG-H3 proteins. Invest Ophthalmol Vis Sci 2002;43: 656-661.
60. Scanlon CS, Van Tubergen EA, Inglehart RC et al. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 2013;92:114-121.
61. Tamiya S, Liu L, Kaplan HJ. Epithelialmesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci 2010;51:2755-2763.
62. Stocks SZ, Taylor SM, Shiels IA. Transforming growth factor-beta1 induces alphasmooth muscle actin expression and fibronectin synthesis in cultured humanretinal pigment epithelial cells. Clin Experiment Ophthalmol 2001; 29:33-37.
63. Gamulescu MA, Chen Y, He S et al. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: Regulation by extracellular matrix proteins and hepatocyte growth factor. Exp Eye Res 2006;83:212-222.
64. Lee J, Ko M, Joo CK. Rho plays a key role in TGF-beta1-induced cytoskeletal rearrangement in human retinal pigment epithelium. J Cell Physiol 2008;216:520-526.
65. Hu YB, Li X, Liang GN et al. Roles of Rho/Rock signaling pathway in silica-induced epithelial-mesenchymal transition in human bronchial epithelial cells. Biomed Environ Sci 2013;26:571-576.
66. Wei J, Li Z, MaC et al. Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion. Cell Biol Int 2013;37: 725-730.
67. Clay MR, Halloran MC. Rho activation is apically restricted by Arhgap1 in neural crest cells and drives epithelial-to-mesenchymal transition. Development 2013;140:3198-3209.
68. Zhang H, Liu X, Liu Y et al. Epithelialmesenchymal transition of rat peritoneal mesothelial cells via Rhoa/Rock pathway. In Vitro Cell Dev Biol Anim 2011;47:165-172.
69. Cho HJ, Yoo J. Rho activation is required for transforming growth factor-betainduced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 2007;31: 1225-1230.
70. Azar KM, Xiao L, Ma J. Baseline obesity status modifies effectiveness of adapted diabetes prevention program lifestyle interventions for weight management in primary care. Biomed Res Int 2013;2013:191209.
71. Gu L, Gao Q, Ni L et al. Fasudil inhibits epithelial-myofibroblast transdifferentiation of human renal tubular epithelial HK-2 cells induced by high glucose. Chem Pharm Bull (Tokyo) 2013;61:688-694.
72. Das S, Becker BN, Hoffmann FM et al. Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. BMC Cell Biol 2009;10:94.
73. Rizzolo LJ. Development and role of tight junctions in the retinal pigment epithelium. Int Rev Cytol 2007;258:195-234.
74. Tribukait A, Rosenhall U, Osterdahl B. Morphological characteristics of the human macula sacculi. Audiol Neurootol 2005;10: 90-96.
75. Chen HC, Zhu YT, Chen SY et al. Wnt signaling induces epithelial-mesenchymal transition with proliferation in ARPE-19 cells upon loss of contact inhibition. Lab Invest 2012;92: 676-687.